Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults

NCT06843317 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

RSV Infection

Interventions

BIOLOGICAL: Candidate vaccine, SCB-1019T
BIOLOGICAL: AREXVY
OTHER: placebo

Sponsor

Clover Biopharmaceuticals USA, LLC